Giorgia Meloni, the Italian prime minister who fostered a friendly relationship with the U.S. president, called Trump’s ...
A Texas investigation into Lululemon Athletica Inc.’s clothing for the presence of so-called “forever chemicals” has sparked a wave of debate across Chinese social media, underscoring the risks the ...
Fast Track Designation recognizes both the urgent need for new therapies in pMN and the compelling early clinical activity generated to date with budoprutug,” said Edgar Charles, M.D., Chief Medical ...
Detailed price information for Promis Neurosciences Inc (PMN-Q) from The Globe and Mail including charting and trades.
Climb Bio has won the Food and Drug Administration's fast-track designation for its proposed budoprutug treatment for the rare kidney disease primary membranous nephropathy, or pMN. The FDA's ...
Budoprutug receives FDA Fast Track status for primary membranous nephropathy after phase 1b data demonstrate clinical activity and safety.
Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced details for the next installment of their R&D Spotlight ...
This press release constitutes a “designated news release” for the purposes of Dream Industrial REIT’s prospectus supplement ...
KYIV, Ukraine (AP) — A Ukrainian drone strike sparked a fire at an oil depot in Russia’s southern Volgograd region, regional authorities said on Saturday. MONTREAL — Montreal’s Olympic Stadium started ...
Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that the ...
If you haven’t guessed, it’s Starbar, a.k.a. Wunderbar. The Wunderbar, with its super-chewy peanut and caramel filling and draping of milk chocolate, was developed by Canadian Linda Allison, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results